Paratek Pharmaceuticals, Inc.

Less than two years after being taken private by Gurnet Capital and Novo Holdings, Paratek Pharmaceuticals has agreed to a merger with Optinose that will expand its product portfolio beyond the anti

“As economic, social, and environmental crises magnify, the world is undergoing some of the most turbulent times we’ve ever seen,” observed Emmanuelle Quilès , worldwide vice president, cardiovascula

Medicare should pay separately for novel antibiotics in the hospital setting, Paratek Pharmaceuticals, Inc. CEO Evan Loh urged during a Duke Margolis webinar on 29 August on approaches to incentiv

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Antibiotics Firm Agrees To Go Private F